140 related articles for article (PubMed ID: 8726009)
1. Variation in postantibiotic effect of clindamycin against clinical isolates of Staphylococcus aureus and implications for dosing of patients with osteomyelitis.
Xue IB; Davey PG; Phillips G
Antimicrob Agents Chemother; 1996 Jun; 40(6):1403-7. PubMed ID: 8726009
[TBL] [Abstract][Full Text] [Related]
2. Postantibiotic effect and postantibiotic sub-minimum inhibitory concentration effect of valnemulin against Staphylococcus aureus isolates from swine and chickens.
Zhao DH; Yu Y; Zhou YF; Shi W; Deng H; Liu YH
Lett Appl Microbiol; 2014 Feb; 58(2):150-5. PubMed ID: 24117872
[TBL] [Abstract][Full Text] [Related]
3. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection.
Lewis RE; Klepser ME; Ernst EJ; Lund BC; Biedenbach DJ; Jones RN
Antimicrob Agents Chemother; 1999 Aug; 43(8):2005-9. PubMed ID: 10428927
[TBL] [Abstract][Full Text] [Related]
5. Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae.
Kuenzi B; Segessenmann C; Gerber AU
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():39-46. PubMed ID: 3501426
[TBL] [Abstract][Full Text] [Related]
6. In vitro studies of the pharmacodynamics of teicoplanin against Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecium.
Odenholt I; Löwdin E; Cars O
Clin Microbiol Infect; 2003 Sep; 9(9):930-7. PubMed ID: 14616681
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal activity of low-dose clindamycin administered at 8- and 12-hour intervals against Staphylococcus aureus, Streptococcus pneumoniae, and Bacteroides fragilis.
Klepser ME; Nicolau DP; Quintiliani R; Nightingale CH
Antimicrob Agents Chemother; 1997 Mar; 41(3):630-5. PubMed ID: 9056005
[TBL] [Abstract][Full Text] [Related]
8. Duration and clinical relevance of postantibiotic effect in relation to the dosing interval.
den Hollander JG; Fuursted K; Verbrugh HA; Mouton JW
Antimicrob Agents Chemother; 1998 Apr; 42(4):749-54. PubMed ID: 9559777
[TBL] [Abstract][Full Text] [Related]
9. Alteration of postantibiotic effect during one dosing interval of tobramycin, simulated in an in vitro pharmacokinetic model.
den Hollander JG; Mouton JW; van Goor MP; Vleggaar FP; Verbrugh HA
Antimicrob Agents Chemother; 1996 Mar; 40(3):784-6. PubMed ID: 8851612
[TBL] [Abstract][Full Text] [Related]
10. Postantibiotic effect of aminoglycosides on staphylococci.
Isaksson B; Maller R; Nilsson LE; Nilsson M
J Antimicrob Chemother; 1993 Aug; 32(2):215-22. PubMed ID: 8226423
[TBL] [Abstract][Full Text] [Related]
11. In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model.
Lepak AJ; Marchillo K; Craig WA; Andes DR
Antimicrob Agents Chemother; 2015 Feb; 59(2):1258-64. PubMed ID: 25512404
[TBL] [Abstract][Full Text] [Related]
12. Postantibiotic effect and postantibiotic sub-mic effect of dirithromycin and erythromycin against respiratory tract pathogenic bacteria.
Dornbusch K; Olofsson C; Holm S
APMIS; 1999 May; 107(5):505-13. PubMed ID: 10335955
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic-Pharmacodynamic Evaluation of Gepotidacin against Gram-Positive Organisms Using Data from Murine Infection Models.
Bulik CC; Okusanya ÓO; Lakota EA; Forrest A; Bhavnani SM; Hoover JL; Andes DR; Ambrose PG
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872075
[TBL] [Abstract][Full Text] [Related]
14. Postantibiotic and post-beta-lactamase inhibitor effects of amoxicillin plus clavulanate.
Thorburn CE; Molesworth SJ; Sutherland R; Rittenhouse S
Antimicrob Agents Chemother; 1996 Dec; 40(12):2796-801. PubMed ID: 9124843
[TBL] [Abstract][Full Text] [Related]
15. Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli.
Fuentes F; Izquierdo J; Martín MM; Gomez-Lus ML; Prieto J
Antimicrob Agents Chemother; 1998 Feb; 42(2):414-8. PubMed ID: 9527796
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics and pharmacodynamics of antimicrobial therapy used in child osteoarticular infections].
Cohen R; Grimprel E
Arch Pediatr; 2007 Oct; 14 Suppl 2():S122-7. PubMed ID: 17956820
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations and ex vivo inhibitory/bactericidal activity of clindamycin after administration of two oral dosages.
Dan M; Yampolsky E; Poch F
Chemotherapy; 1997; 43(4):227-31. PubMed ID: 9209778
[TBL] [Abstract][Full Text] [Related]
18. Assessment of methicillin and clindamycin resistance patterns in Staphylococcus aureus isolated from a tertiary hospital in Turkey.
Tekin A; Dal T; Deveci O; Tekin R; Atmaca S; Dayan S
Infez Med; 2013 Jun; 21(2):111-6. PubMed ID: 23774974
[TBL] [Abstract][Full Text] [Related]
19. The postantibiotic effect of selected antibiotics on Staphylococcus aureus Newbould 305 from bovine intramammary infection.
Owens WE; Washburn PJ; Ray CH
Zentralbl Veterinarmed B; 1993 Dec; 40(9-10):603-8. PubMed ID: 8128793
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae.
Licata L; Smith CE; Goldschmidt RM; Barrett JF; Frosco M
Antimicrob Agents Chemother; 1997 May; 41(5):950-5. PubMed ID: 9145850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
